Therapeutics News and Research

RSS

Smokers who switch to e-cigarettes show improvement in their vascular health

Cigarette smokers who switch to nicotine containing vaporizers could significantly improve their vascular health, a major University of Dundee study has concluded.

15 Nov 2019

Study shows importance of targeted antibody treatment for patients with wet macular degeneration

Wet age-related macular degeneration is one of the leading causes of blindness in the U.S. Breakthrough treatments come with a steep price tag and treatment burden for the patient, but a new study suggests their benefits to patient health and society top billions of dollars, or more, if adherence could be improved.

15 Nov 2019

LUNAC announces spin out with £2.65 million funding to develop advanced anticoagulants

LUNAC Therapeutics today announced it has spun out of the University of Leeds with £2.65M funding in the first close of a Series A financing round.

15 Nov 2019

Earliest stage of hearing loss is linked to cognitive decline

Research has shown that adults with age-related hearing loss have higher rates of cognitive decline. Now, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found that even the earliest stage of hearing loss-when hearing is still considered normal - is linked to cognitive decline.

14 Nov 2019

Dopamine D2 receptor modulates Wnt expression, controls cell proliferation

The dopamine D2 receptor has a previously unobserved role in modulating Wnt expression and control of cell proliferation, according to a new study from the George Washington University and the University of Pittsburgh.

14 Nov 2019

Promising method to identify aggressive breast cancers that will respond to immunotherapy

University of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a promising method to identify aggressive breast cancer tumors that will respond to drugs that unleash the immune system against cancer.

14 Nov 2019

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses, aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

14 Nov 2019

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

14 Nov 2019

First Ebola vaccine prequalified by WHO for use in high-risk countries

The world's first Ebola vaccine has been prequalified by the World Health Organization (WHO).

14 Nov 2019

Lonza launches new basal and feed medium to optimize protein production

Lonza has further expanded its cell culture media portfolio with the addition of the eCHO Basal Medium and Feed, which has been designed to optimize protein production by delivering a consistent yield and highly viable cells while keeping lactate levels to a minimum for optimal protein integrity.

From Lonza 14 Nov 2019

LG Chem Life Sciences expands collaboration with Avacta

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences, part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas.

From LG Chem Life Sciences Innovation Center, Inc. 14 Nov 2019

Study shows potential of phage therapy to treat alcoholic liver disease

Bacteriophages (phages) are viruses that specifically destroy bacteria. In the early 20th century, researchers experimented with phages as a potential method for treating bacterial infections.

13 Nov 2019

Tall people more likely to develop atrial fibrillation

Size may matter when it comes to having a safe and steady heart. A new study shows tall people are more likely to develop from an irregular heartbeat, known as atrial fibrillation (AFib).

13 Nov 2019

The arts could benefit health finds landmark WHO report

The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.

13 Nov 2019

Johns Hopkins launches new center for 'immunoengineering' research

If the saying that two heads are better than one is true, then joining two fields of science may be better than one to spur more advances in medicine.

13 Nov 2019

Standard methods not adequate to detect prosthetic joint infections in rheumatic disease patients

Standard diagnostic methods are not adequate to identify prosthetic joint infections in patients with rheumatic diseases, according to findings from a new study by researchers from Hospital for Special Surgery in New York City.

12 Nov 2019

'Pre-habilitation' program before knee replacement could lead to better outcomes

Rehabilitation after knee replacement is an essential part of the recovery process. But what's the best way to prepare patients before the procedure?

12 Nov 2019

Cardiac-specific biomarkers may help predict CVD risk factors early

A new review article provides valuable insights into how traditional and emerging cardiac-specific biomarkers and their associated cardiovascular disease (CVD) risk factors may help point to effective preventive interventions in high-risk obese populations starting at an early stage of disease development.

12 Nov 2019

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers Cancer Institute of New Jersey researcher Hossein Khiabanian, PhD, has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia with the aim of developing research models that may help investigators better understand how CLL cells are influenced by new therapies.

11 Nov 2019

Where patient resides influences post-op care and rehab after hip replacement, study shows

A new study finds that the community in which one lives influences whether they receive postoperative care and rehabilitation after elective hip replacement surgery in a facility or at home.

11 Nov 2019

Therapeutics News and Research

Smokers who switch to e-cigarettes show improvement in their vascular health

Study shows importance of targeted antibody treatment for patients with wet macular degeneration

LUNAC announces spin out with £2.65 million funding to develop advanced anticoagulants

Earliest stage of hearing loss is linked to cognitive decline

Dopamine D2 receptor modulates Wnt expression, controls cell proliferation

Promising method to identify aggressive breast cancers that will respond to immunotherapy

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

First Ebola vaccine prequalified by WHO for use in high-risk countries

Lonza launches new basal and feed medium to optimize protein production

LG Chem Life Sciences expands collaboration with Avacta

Study shows potential of phage therapy to treat alcoholic liver disease

Tall people more likely to develop atrial fibrillation

The arts could benefit health finds landmark WHO report

Johns Hopkins launches new center for 'immunoengineering' research

Standard methods not adequate to detect prosthetic joint infections in rheumatic disease patients

'Pre-habilitation' program before knee replacement could lead to better outcomes

Cardiac-specific biomarkers may help predict CVD risk factors early

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Where patient resides influences post-op care and rehab after hip replacement, study shows

Industry Focus eBook - Microbiome (1st edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News